A Biotechnologist from the Federal University of Paraíba (2023), currently affiliated with the Laboratory of Immunology of Infectious Diseases as a master's student. During my undergraduate studies, in the same laboratory, I evaluated synthetic compounds for their potential anti-Leishmania properties and their potential immunomodulatory effects through both in silico and in vitro assays. Furthermore, I collaborated on projects focused on assessing immune cell responses triggered by peptide antigens in COVID-19 vaccinated patients, as well as in patients who experienced mild COVID-19 and subsequently developed tuberculosis. In these projects, I evaluated the expression of prognostic immunological markers within the CD8+, CD4+, and B lymphocyte subpopulations by flow cytometry analysis, within the same research group. I was associated with the Multiuser Laboratory of Bioinformatics and Data Analysis, contributing to projects aimed at identifying analogs with the potential to inhibit structural or non-structural proteins of SARS-CoV-2.I am interested in RD in the following areas: cellular and molecular immunology, molecular and cellular biology, virology, infectious diseases, bioinformatics, and technologies in vaccine platforms and diagnostic tests.